Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain.

Schulz, M; Griese-Mammen, N; Müller, U

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain.

Schulz, M

Griese-Mammen, N Müller, U

Permalink

Publisher:: SPRINGER
Publication Type:: Journal Article
Citation:: Int J Clin Pharm, 2022
Issue Date:: 2022-11-17

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (697.76 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Schulz, M https://orcid.org/0000-0002-5876-7322
dc.contributor.author	Griese-Mammen, N
dc.contributor.author	Müller, U
dc.date.accessioned	2023-02-21T22:05:06Z
dc.date.available	2022-09-19
dc.date.available	2023-02-21T22:05:06Z
dc.date.issued	2022-11-17
dc.identifier.citation	Int J Clin Pharm, 2022
dc.identifier.issn	2210-7703
dc.identifier.issn	2210-7711
dc.identifier.uri	http://hdl.handle.net/10453/166293
dc.description.abstract	Over the last two decades, community pharmacy has experienced major changes as the role of pharmacists is evolving from a product to a service and a patient focus. As part of this change, new and innovative clinical pharmacy services aimed at improving medicines use and patient outcomes have been designed, both nationally and internationally. Since June 2022, five services are reimbursed by all statutory health insurance funds and private insurance companies in Germany: medication review for patients with polymedication; blood pressure control in hypertension; assuring proper inhalation techniques for patients receiving a new device or a device change; medication review including a follow-up for patients taking oral anticancer drugs or immunosuppressants post-transplantation. Beyond reimbursement, the upscaling and sustainable provision of these professional services are now the main challenges. Implementation research will provide important information for the further development of pharmaceutical care programs.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	SPRINGER
dc.relation.ispartof	Int J Clin Pharm
dc.relation.isbasedon	10.1007/s11096-022-01492-7
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1115 Pharmacology and Pharmaceutical Sciences, 1199 Other Medical and Health Sciences
dc.subject.classification	Pharmacology & Pharmacy
dc.title	Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain.
dc.type	Journal Article
utslib.location.activity	Netherlands
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
utslib.for	1199 Other Medical and Health Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.date.updated	2023-02-21T22:05:05Z
pubs.publication-status	Published online

Abstract:

Over the last two decades, community pharmacy has experienced major changes as the role of pharmacists is evolving from a product to a service and a patient focus. As part of this change, new and innovative clinical pharmacy services aimed at improving medicines use and patient outcomes have been designed, both nationally and internationally. Since June 2022, five services are reimbursed by all statutory health insurance funds and private insurance companies in Germany: medication review for patients with polymedication; blood pressure control in hypertension; assuring proper inhalation techniques for patients receiving a new device or a device change; medication review including a follow-up for patients taking oral anticancer drugs or immunosuppressants post-transplantation. Beyond reimbursement, the upscaling and sustainable provision of these professional services are now the main challenges. Implementation research will provide important information for the further development of pharmaceutical care programs.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/166293